AVITA Medical (AVHHL) Net Cash Flow Growth (1y) (2020 - 2025)
Analysis
AVITA Medical (AVHHL) Net Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.92 Bn | 179.32 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 124.64 Bn | 119.43 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 118.74 Bn | 109.92 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 104.84 Bn | 101.36 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 67.36 Bn | 66.82 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 33.93 Bn | 32.48 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 32.38 Bn | 30.43 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | -54.17% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -13.93% |
| Sep 30, 2025 | 170.09% |
| Jun 30, 2025 | -629.74% |
| Mar 31, 2025 | 115.87% |
| Dec 31, 2024 | 84.17% |
| Sep 30, 2024 | -91.13% |
| Jun 30, 2024 | -94.69% |
| Mar 31, 2024 | -152.27% |
| Dec 31, 2023 | -4,633.94% |
| Mar 31, 2023 | 130.92% |
| Dec 31, 2022 | 99.05% |
| Mar 31, 2022 | -158.00% |
| Dec 31, 2021 | -963.48% |
| Sep 30, 2021 | 109.36% |
| Jun 30, 2021 | -118.94% |
| Mar 31, 2021 | 822.38% |
| Dec 31, 2020 | -108.35% |
| Sep 30, 2020 | -58.67% |